893 related articles for article (PubMed ID: 26921847)
21. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
22. Surgical closure, mainly with glue injection and anti-tumour necrosis factor α, in fistulizing perianal Crohn's disease: A multicentre randomized controlled trial.
Abramowitz L; Brochard C; Pigot F; Roumeguere P; Pillant H; Vinson Bonnet B; Faucheron JL; Senéjoux A; Bonnaud G; Meurette G; Fayette JM; Train C; Staumont G; Siproudhis L; Bouchard D
Colorectal Dis; 2022 Feb; 24(2):210-219. PubMed ID: 34623746
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure.
Echarri A; Castro J; Barreiro M; Carpio D; Pereira S; Lorenzo A
J Crohns Colitis; 2010 Dec; 4(6):654-60. PubMed ID: 21122576
[TBL] [Abstract][Full Text] [Related]
24. Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).
Le Baut G; Peyrin-Biroulet L; Bouguen G; Gornet JM; Stefanescu C; Amiot A; Laharie D; Altwegg R; Fumery M; Trang C; Vuitton L; Simon M; Gilletta de Saint Joseph C; Nahon S; Caillo L; Del Tedesco E; Plastaras L; Aubourg A; Pineton de Chambrun G; Seksik P; Viennot S
Aliment Pharmacol Ther; 2018 Oct; 48(8):831-838. PubMed ID: 30194687
[TBL] [Abstract][Full Text] [Related]
25. Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
McCurdy JD; Parlow S; Dawkins Y; Samji K; Rhee GG; Oliveira L; Macdonald B; Sabri E; Murthy S
Dig Dis Sci; 2020 Jun; 65(6):1784-1789. PubMed ID: 31642006
[TBL] [Abstract][Full Text] [Related]
26. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
Meima-van Praag EM; van Rijn KL; Wasmann KATGM; Snijder HJ; Stoker J; D'Haens GR; Gecse KB; Gerhards MF; Jansen JM; Dijkgraaf MGW; van der Bilt JDW; Mundt MW; Spinelli A; Danese S; Bemelman WA; Buskens CJ
Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):617-626. PubMed ID: 35427495
[TBL] [Abstract][Full Text] [Related]
27. Real-world Experience of Anti-tumor Necrosis Factor Therapy for Internal Fistulas in Crohn's Disease: A Retrospective Multicenter Cohort Study.
Kobayashi T; Hishida A; Tanaka H; Nuki Y; Bamba S; Yamada A; Fujii T; Shinzaki S; Yokoyama Y; Yoshida A; Ozeki K; Ashizuka S; Kamata N; Nanjo S; Kakimoto K; Nakamura M; Matsui A; Yamauchi R; Takahashi S; Tomizawa T; Yoshino T; Hibi T
Inflamm Bowel Dis; 2017 Dec; 23(12):2245-2251. PubMed ID: 29084079
[TBL] [Abstract][Full Text] [Related]
28. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
Tonelli F; Giudici F; Asteria CR
Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
[TBL] [Abstract][Full Text] [Related]
30. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn's Disease: A Systematic Review.
Tandon P; Rhee GG; Schwartz D; McCurdy JD
Dig Dis Sci; 2019 Nov; 64(11):3066-3077. PubMed ID: 31030304
[TBL] [Abstract][Full Text] [Related]
31. Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience.
Guidi L; Ratto C; Semeraro S; Roberto I; De Vitis I; Papa A; Marzo M; Parello A; Foglietto G; Doglietto GB; Gasbarrini GB; Fedeli G
Tech Coloproctol; 2008 Jun; 12(2):111-7. PubMed ID: 18545878
[TBL] [Abstract][Full Text] [Related]
32. Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing.
Wiese DM; Beaulieu D; Slaughter JC; Horst S; Wagnon J; Duley C; Annis K; Nohl A; Herline A; Muldoon R; Geiger T; Wise PE; Schwartz DA
Inflamm Bowel Dis; 2015 Jul; 21(7):1594-9. PubMed ID: 25985245
[TBL] [Abstract][Full Text] [Related]
33. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed?
Tanaka S; Matsuo K; Sasaki T; Nakano M; Sakai K; Beppu R; Yamashita Y; Maeda K; Aoyagi K
Hepatogastroenterology; 2010; 57(97):3-7. PubMed ID: 20422862
[TBL] [Abstract][Full Text] [Related]
34. Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn's disease: a retrospective observational study.
Park MY; Yoon YS; Lee JL; Park SH; Ye BD; Yang SK; Yu CS
Stem Cell Res Ther; 2021 Jul; 12(1):401. PubMed ID: 34256838
[TBL] [Abstract][Full Text] [Related]
35. Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option?
Rinawi F; Greer MC; Walters T; Church PC; Ricciuto A; Langer JC; Griffiths AM
J Pediatr Surg; 2022 Nov; 57(11):569-574. PubMed ID: 35491271
[TBL] [Abstract][Full Text] [Related]
36. Combined modality treatment for complex fistulating perianal Crohn's disease.
Antakia R; Shorthouse AJ; Robinson K; Lobo AJ
Colorectal Dis; 2013 Feb; 15(2):210-6. PubMed ID: 22672653
[TBL] [Abstract][Full Text] [Related]
37. Management of perianal Crohn's disease.
Rutgeerts P
Can J Gastroenterol; 2000 Sep; 14 Suppl C():7C-12C. PubMed ID: 11023554
[TBL] [Abstract][Full Text] [Related]
38. Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.
Papamichael K; Cheifetz AS
World J Gastroenterol; 2017 Sep; 23(34):6197-6200. PubMed ID: 28974885
[TBL] [Abstract][Full Text] [Related]
39. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.
Rayen J; Currie T; Gearry RB; Frizelle F; Eglinton T
Tech Coloproctol; 2017 Feb; 21(2):119-124. PubMed ID: 28066859
[TBL] [Abstract][Full Text] [Related]
40. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
